ACT Genomics lands funding

ACT Genomics, a DNA sequencing-based cancer solution provider, has raised an undisclosed amount of funding.

ACT Genomics, a DNA sequencing-based cancer solution provider, has raised an undisclosed amount of funding. The investors included Aflac Ventures LLC and Kyoto University Innovation Capital.

Source: Press Release